| 2926.90.01 | 00 | 2-Cyano-4-nitroaniline | kg | Free | | 15.4￠/kg + 41% |
| 2926.90.05 | 00 | 2-Amino-4-chlorobenzonitrile (5-Chloro-2- cyanoaniline); 2-Amino-5-chlorobenzonitrile; 4-Amino-2-chlorobenzonitrile; (Cyanoethyl)(hydroxyethyl)-m-toluidine; p-Cyanophenyl acetate; Phthalonitrile; and Tetrachloro-3-cyanobenzoic acid, methyl ester | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 41% |
| 2926.90.08 | 00 | Benzonitrile | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 41% |
| 2926.90.11 | 00 | Dichlorobenzonitriles: | | | | |
| 2926.90.11 | 00 | 2,6-Dichlorobenzonitrile | kg | Free | | 15.4￠/kg + 41% |
| 2926.90.14 | 00 | p-Chlorobenzonitrile; and Verapamil hydrochloride | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX,P) 2.9% (SG) | 15.4￠/kg + 65.5% |
| 2926.90.17 | 00 | o-Chlorobenzonitrile | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 3.4% (SG) | 15.4￠/kg + 65.5% |
| 2926.90.19 | 00 | N,N-Bis(2-cyanoethyl)aniline; and 2,6-Difluorobenzonitrile | kg | Free | | 15.4￠/kg + 65.5% |
| 2926.90.23 | 00 | 3,5-Dibromo-4-hydroxybenzonitrile (Bromoxynil) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 40.5% |
| 2926.90.50 | 10 | Malononitrile | kg | | | |
| 2931.00.05 | 00 | Diphenyldichlorosilane; and Phenyltrichlorosilane | kg | Free | | 15.4￠/kg + 68.5% |
| 2931.00.70 | 00 | N,N'-Bis(trimethylsilyl)urea; 3-(Hydroxymethylphosphinyl)-1-propanoic acid, 2-hydroxyethyl ester; and 2-Phosphonobutane-1,2,4-tricarboxylic acid and its salts | kg | Free | | 25% |
| 2931.00.90 | 10 | Organo-silicon compounds | kg | | | |
| 2933.33.00 | 00 | Alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN), fentanyl (INN), ketobemidone (INN), methylphenidate (INN), pentazocine (INN), pethidine (INN), pethidine (INN) intermediate A, phencyclidine (INN) (PCP), phenoperidine (INN), pipradrol (INN), piritramide (INN), propiram (INN) and trimeperidine (INN); salts thereof | kg | Free | | 15.4￠/kg + 149.5% |
| 2933.39.31 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4￠/kg + 149.5% |
| 2933.39.61 | 10 | 3-Quinuclidinyl benzilate | kg | | | |
| 2933.59.46 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4￠/kg + 149.5% |
| 2933.59.85 | 00 | 2-Amino-4-chloro-6-methoxypyrimidine; 2-Amino-4,6-dimethoxypyrimidine; and 6-Methyluracil | kg | Free | | 30.5% |
| 2933.71.00 | 00 | 6-Hexanelactam (ε-Caprolactam) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2￠/kg + 2.7% (SG) | 15.4￠/kg + 40% |
| 2933.99.06 | 00 | α-Butyl- α-(4-chlorophenyl)-1H-1,2,4- triazole-1- propanenitrile (Myclobutanil); and α-[2-(4-Chlorophenyl)ethyl]- α-phenyl-1H- 1,2,4-triazole-1-propanenitrile (Fenbuconazole) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 64.5% |
| 2933.99.55 | | Drugs primarily affecting the central nervous system: | | | | |
| 2933.99.58 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents: | | | | |
| 2934.30.23 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4￠/kg + 149.5% |
| 2934.91.00 | 00 | Aminorex (INN), brotizolam (INN), clotiazepam (INN), cloxazolam (INN), dextromoramide (INN), haloxazolam (INN), ketazolam (INN), mesocarb (INN), oxazolam (INN), pemoline (INN), phendimetrazine (INN), phenmetrazine (INN) and sufentanil (INN); salts thereof | kg | Free | | 15.4￠/kg + 52% |
| 2934.99.01 | 00 | Mycophenolate mofetil | kg | Free | | 15.4￠/kg + 45% |
